AUSTER MARTIN (Chief Financial Officer) sold 12.8% of their position (7K shares) of VENTYX BIOSCIENCES, INC. on the open market
Open‑market sale worth $231.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/19/2023ACC: 0001209191-23-024854
Officer· Chief Financial Officer
Since Oct 2021
-7K
Net shares
Net seller
$231.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
7K acquired · 14K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7K
Price / share
$3.45
Trade value
$24.15K
% of position
14.7%
4/17/2023
47.65K→54.65K
Common Stock
Direct
Shares
−7K
Price / share
$33.00
Trade value
$231.01K
% of position
12.8%
4/17/2023
54.65K→47.65K
Total
Net shares
+0.00
Net value
-$206.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/17/2023 | M · Option Exercise | +7K | $3.45 | $24.15K | 14.7% | 47.65K | 54.65K |
| Common Stock Direct | 4/17/2023 | S · Sale | −7K | $33.00 | $231.01K | 12.8% | 54.65K | 47.65K |
| Total | +0.00 | -$206.86K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
7K shares
Shares
−7K
Strike price
3.45
Held after
303.18K
Exercisable
—
4/17/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock7K shares | 4/17/2023 | M · Option Exercise | −7K | 3.45 | — | 303.18K |